The discovery and development of omalizumab for the treatment of asthma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The discovery and development of omalizumab for the treatment of asthma
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 10, Issue 9, Pages 1033-1042
Publisher
Informa Healthcare
Online
2015-05-16
DOI
10.1517/17460441.2015.1048220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omalizumab Modulates Bronchial Reticular Basement Membrane Thickness and Eosinophil Infiltration in Severe Persistent Allergic Asthma Patients
- (2017) A.M. Riccio et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- EXCELS study results do not rule out potential cancer risk with omalizumab
- (2015) Jie Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cost-effectiveness of asthma therapy: a comprehensive review
- (2015) Javier Domínguez-Ortega et al. JOURNAL OF ASTHMA
- Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation
- (2014) G Norman et al. HEALTH TECHNOLOGY ASSESSMENT
- Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
- (2014) Pierluigi Mauri et al. IMMUNOLOGY LETTERS
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in Children
- (2014) Amelia Licari et al. PEDIATRIC DRUGS
- New strategies with anti-IgE in allergic diseases
- (2014) Stephen T Holgate World Allergy Organization Journal
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
- (2013) Kate McKeage DRUGS
- Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
- (2013) Antoine Deschildre et al. EUROPEAN RESPIRATORY JOURNAL
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects
- (2013) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling
- (2013) Michael Roth et al. PLoS One
- The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma
- (2013) G.-J. Braunstahl et al. RESPIRATORY MEDICINE
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands
- (2012) Floortje van Nooten et al. JOURNAL OF MEDICAL ECONOMICS
- Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up
- (2012) Francesco Menzella et al. Therapeutic Advances in Respiratory Disease
- Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE
- (2011) Philip J. Lowe et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Omalizumab in patients with severe asthma: the XCLUSIVE study
- (2011) Christian Schumann et al. Clinical Respiratory Journal
- Therapy with omalizumab for patients with severe allergic asthma improves asthma control and reduces overall healthcare costs
- (2011) R. W. Costello et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
- (2011) William W. Busse et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma
- (2010) Gustavo J. Rodrigo et al. CHEST
- Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma
- (2010) Henry Milgrom et al. CURRENT MEDICAL RESEARCH AND OPINION
- Decreases in human dendritic cell–dependent TH2-like responses after acute in vivo IgE neutralization
- (2010) John T. Schroeder et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- After 6âyears with Xolair; a 3-year withdrawal follow-up
- (2009) A. Nopp et al. ALLERGY
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
- (2009) Bob Lanier et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
- (2009) G. Brusselle et al. RESPIRATORY MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now